Emerging Technology and Best Practices Seminar Series

Next Generation Manufacturing Challenges
for Life Sciences
Friday, November 14, 2003

The abundance of data collected by decoding the Human and other Genomes is leading to our understanding the function of individual genes in DNA and the role of the proteins that are coded in the DNA. This will consequently enable us to control expression of proteins in cells, potentially revolutionizing the way medicine is practiced. However, this vast amount of data is necessitating a paradigm shift in biological research, medical diagnostics and drug discovery from "one-off" experiments to high-throughput parallel experimentation. For example, protein, peptide and ligand arrays promise to be of enormous importance in clinical, pharmaceutical and basic biological research. This will undoubtedly lead to high potency drugs that are highly targeted to specific ailments. While great progress is currently being made in research laboratories, the transition to practice will require a new class of manufacturing solutions and intelligent devices that are able to cost-effectively develop, produce and deliver these new, highly targeted drugs. Please join us on November 14th at the Emerging Technologies Seminar to explore the next generation manufacturing challenges for life sciences.

Download Flyer

Agenda for November 14, 2003 Emerging Technology and Best Industry Practices Seminar Next Generation Manufacturing Challenges for Life Sciences 9th Floor, The Photonics Center 8 St. Mary's Street Boston, MA 02215
8:00	Continental Breakfast
8:30	Welcome Dean David Campbell, Boston University, College of Engineering
8:40	Dr. Gradimir Georgevich, Program Manager National Institute of Standards and Technology, Advanced Technology Program, Chemistry and Life Sciences Office Innovative Approaches to Manufacturing Challenges
9:10	Mr. John Machulski, Project Director, Lonza Biologics The Contract Manufacturing Model in Biopharmaceuticals
9:40	Break
Session 1: Automating Drug Discovery
10:10	Dr. Andre Sharon Director, Fraunhofer Center for Manufacturing Innovation and Professor Department of Manufacturing Engineering, Boston University Fraunhofer Activities in Biotech Manufacturing
11:00	Dr. Andrew Bullen, Group Leader, Instrumentation Technologies Group Bristol-Myers Squibb Company Automating Drug Discovery: Current and Future Challenges
11:30	Dr. Robert Ronstadt Vice President and Director, Technology Commercialization Institute Boston University
11:45	Lunch
Session 2: Producing Pharmaceuticals
12:50	Mr. Scott Sarazen, Biotech Ombudsman, Senior Vice President, MassDevelopment Organizational Drivers for Growing in Biosciences Companies
1:20	Panel Discussion Ms. Janice Bourque, President, Massachusetts Biotechnology Council Dr. Una Ryan, President and Chief Executive Officer, AVANT Immunotherapeutics Mr. Bennett Green, Senior Vice President of Global Quality Operations, Genzyme
2:20	Break
2:50	Mr. Gary Welch, Director of Production, Abbott Bioresearch Center Regulatory and Economic Challenges in Biotechnology Manufacturing
3:20	Dr. Keith Dionne, Vice President, Strategy, Millennium Pharmaceuticals Incorporating Manufacturing and Automation in Pharmaceutical R&D

Back to top